type here...

Melissa Newham

Melissa Newham is a postdoctoral researcher and lecturer in the Department of Management, Technology, and Economics at ETH Zürich. After doctoral studies at KU Leuven, DIW Berlin, Yale University and the University of Virginia, she received her PhD from KU Leuven in 2021. Her research focuses on economic policy, regulation, competition, and healthcare markets.
Antitrust and Competition

Do Private Equity and Other Investors Harm Competition in the Pharmaceutical Industry?

Melissa Newham
Melissa Newham reviews how investors can alter the incentives and behavior of pharmaceutical companies to reduce competition and consumer welfare through common ownership and “rollup” deals.

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.